Skip to content
The African Exponent DATA
Resources

Review pending. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (9 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review

CAP Plc

CAP · Nigerian Exchange · Company statements

On this page
Company details
Legal name
Chemical and Allied Products Plc
Listing
CAP on the Nigerian Exchange, active · ISIN NGCAP0000009 (observed 2026-10-08)
Sector
Not classified (our classification from the stated principal activity)
Financial year ends
31 December

Overview

Year ended 31 December 2024 · annual report, signed / final · source

  • Revenue

    NGN 36.4 billion

    36,362,182 NGN thousands · p34

    +52.2% vs 2023

  • Operating profit / (loss)

    NGN 5.45 billion

    5,449,620 NGN thousands · p34

    +67.5% vs 2023

  • Profit / (loss) for the year

    NGN 3.81 billion

    3,807,258 NGN thousands · p34

    +51.4% vs 2023

  • Total assets

    NGN 19.7 billion

    19,677,179 NGN thousands · p35

    +28.0% vs 2023

  • Total equity

    NGN 10.6 billion

    10,636,487 NGN thousands · p35

    +33.5% vs 2023

  • Cash from operations

    NGN 5.03 billion

    5,034,673 NGN thousands · p36

    +40.6% vs 2023

Large amounts are rounded for reading (NGN million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.

Financial statements

Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in NGN thousands unless the row says otherwise; brackets are negative.

† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table

Column sources

  • FY2024 — annual report, signed / final; reported for the year · source
  • FY2023 — annual report, signed / final; comparative in the FY2024 filing · source

Income statement

Income statement, NGN thousands. Columns: FY2024 — annual report (signed / final), as reported for the year; FY2023 — annual report (signed / final), comparative reported in the annual report for 2024.
Line (as printed) FY2024Annual reportreported for the yearFY2023Annual reportcomparative in FY2024 filing
Revenue 36,362,182 23,890,279
Cost of sales (21,596,084) (14,878,476)
Gross profit 14,766,098 9,011,803
Impairment (loss)/reversal on trade and other receivables (55,312) 31,907
Selling and marketing expenses (3,534,931) (2,363,046)
Administrative expenses (6,163,059) (3,960,948)
Other income 436,824 533,313
Operating profit 5,449,620 3,253,029
Finance income 644,762 681,245
Finance cost (30,134) (155,346)
Net finance income1 614,628 525,899
Profit before taxation 6,064,248 3,778,928
Income tax expense (2,256,990) (1,264,192)
Profit for the year 3,807,258 2,514,736
Other comprehensive income for the year net of tax –2 –2
Total comprehensive income for the year 3,807,258 2,514,736
  1. Printed “-”, read as nil: subtotal_arithmetic: is.total_comprehensive_income.
Notes and alternative reported figures (1)
  1. “Net finance income” is an issuer-specific line, not mapped to a shared definition: Finance income less finance cost.

Balance sheet

Balance sheet, NGN thousands. Columns: FY2024 — annual report (signed / final), as reported for the year; FY2023 — annual report (signed / final), comparative reported in the annual report for 2024.
Line (as printed) FY2024Annual reportreported for the yearFY2023Annual reportcomparative in FY2024 filing
Property, plant and equipment 3,377,677 1,990,608
Right of use assets 6,850 7,028
Intangible assets 266,475 327,648
Finance lease receivable1 10,372 10,372
Non-current assets (unlabelled subtotal) 3,661,374 2,335,656
Inventories 6,648,523 5,019,523
Trade and other receivables 1,179,836 948,385
Prepayments2 1,172,711 1,846,529
Cash and cash equivalents 7,014,735 4,996,425
Current assets before assets held for sale (unlabelled subtotal)3 16,015,805 12,810,862
Assets held for sale4 –5 227,003
Current assets (unlabelled subtotal) 16,015,805 13,037,865
Total assets 19,677,179 15,373,521
Lease Liability 7,959 7,959
Employee benefit obligations 277,824 –6
Deferred tax liabilities 844,200 489,094
Non-current liabilities (unlabelled subtotal) 1,129,983 497,053
Trade and other payables 4,554,041 4,141,179
Provisions 133,254 100,254
Current income tax liabilities 1,919,902 1,121,788
Borrowings –7 39,830
Dividend payable 1,303,512 1,503,710
Current liabilities (unlabelled subtotal) 7,910,709 6,906,761
Total liabilities 9,040,692 7,403,814
Ordinary share capital 407,374 407,374
Share premium 523,850 523,850
Other Reserves from business combination8 968,267 968,267
Retained Earnings 8,736,996 6,070,216
Equity attributable to equity holders of the Company 10,636,487 7,969,707
Total equity 10,636,487 7,969,707
Total equity and liabilities 19,677,179 15,373,521
  1. Printed “-”, read as nil: subtotal_arithmetic: bs.current_assets.
  2. Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_liabilities.
  3. Printed “-”, read as nil: subtotal_arithmetic: bs.current_liabilities.
Notes and alternative reported figures (5)
  1. “Finance lease receivable” is an issuer-specific line, not mapped to a shared definition: Note 18b: non-current.
  2. “Prepayments” is an issuer-specific line, not mapped to a shared definition: Note 19: printed apart from trade and other receivables.
  3. “Current assets before assets held for sale (unlabelled subtotal)” is an issuer-specific line, not mapped to a shared definition: Unlabelled subtotal printed after cash and cash equivalents, before assets held for sale (p35).
  4. “Assets held for sale” is an issuer-specific line, not mapped to a shared definition: Note 14.2.
  5. “Other Reserves from business combination” is an issuer-specific line, not mapped to a shared definition: Note 24.

Cash flow

Cash flow, NGN thousands. Columns: FY2024 — annual report (signed / final), as reported for the year; FY2023 — annual report (signed / final), comparative reported in the annual report for 2024.
Line (as printed) FY2024Annual reportreported for the yearFY2023Annual reportcomparative in FY2024 filing
Cash generated from operations 6,138,443 4,445,711
Income taxes paid (1,103,770) (864,354)
Net cash generated from operating activities 5,034,673 3,581,357
Purchase of property plant and equipment (1,864,845) (713,267)
Proceeds from sale of property plant and equipment 45,180 71,269
Proceeds from sale of assets held for sale1 45,912 14,009
Purchase of intangible Assets (16,416) (7,770)
Interest received 184,446 308,123
Net cash flow used in investing activities (1,605,723) (327,636)
Dividend paid (1,262,859) (1,262,859)
Dividends transferred to the registrar2 (185,633) –3
Dividend refunded by the registrar4 107,816 96,443
Repayment of lease liabilities (1,452) (2,759)
Proceeds from borrowings 750,000 226,958
Interest paid (28,682) (153,918)
Principal repayment on borrowings (789,830) (922,239)
Net cash flow used in financing activities (1,410,640) (2,018,374)
Net increase in cash and cash equivalents 2,018,310 1,235,347
Cash and cash equivalents at beginning of period 4,996,425 3,761,078
Cash and cash equivalents at end of period 7,014,735 4,996,425
  1. Printed “-”, read as nil: subtotal_arithmetic: cf.cash_from_financing.
Notes and alternative reported figures (3)
  1. “Proceeds from sale of assets held for sale” is an issuer-specific line, not mapped to a shared definition: Investing activities.
  2. “Dividends transferred to the registrar” is an issuer-specific line, not mapped to a shared definition: Financing activities (note 12).
  3. “Dividend refunded by the registrar” is an issuer-specific line, not mapped to a shared definition: Financing activities (note 12).

Per share and shares

Per share and shares. Columns: FY2024 — annual report (signed / final), as reported for the year; FY2023 — annual report (signed / final), comparative reported in the annual report for 2024.
Line (as printed) FY2024Annual reportreported for the yearFY2023Annual reportcomparative in FY2024 filing
Earnings / (loss) per share (per share)3 4.671 3.092
  1. Printed as 467 kobo; value converted to NGN at 100 kobo = 1 NGN.
  2. Printed as 309 kobo; value converted to NGN at 100 kobo = 1 NGN.
Notes and alternative reported figures (1)
  1. Earnings / (loss) per share: printed as “Basic and diluted Earnings Per Share (kobo)”.

Segments

Segment data not yet collected for this company in the pilot.

Dividends

Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.

Dividend events, the issuer's wording, and amounts as printed
Year endedEventWording as printedAmountUnitSource
31 Dec 2024 Dividends paid (cash flow statement) Dividend paid (1,262,859) NGN thousands Annual report, p36
31 Dec 2023 Dividends paid (cash flow statement) Dividend paid (1,262,859) NGN thousands Annual report, p36

Sources

Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.

  • Chemical and Allied Products Plc Annual Report for the Year Ended 31 December 2024

    Year ended 31 December 2024 · Annual report · signed / final

    Audit: KPMG Professional Services (Chartered Accountants), Lagos, unmodified opinion · signed

    Auditor's sign-off: Mohammed M. Adama, FCA, for KPMG Professional Services

    Final status: Independent auditor's report to the shareholders of Chemical and Allied Products Plc by KPMG Professional Services (Mohammed M. Adama, FCA, FRC/2012/ICAN/00000000443), unmodified opinion (p30), hand-signed with an ICAN seal and dated 29 March 2025 (p33, page image). Statements approved and authorised for issue by the board on 27 March 2025 and signed by the chairman, the managing director and the chief financial officer (p35, page image).

    Document date
    29 Mar 2025
    Auditor's report
    29 Mar 2025
    Board approval
    27 Mar 2025
    Retrieved by us
    8 Oct 2026 (not a publication date)
    Used for
    statement columns FY2024, FY2023
    Basis
    company statements · NGN thousands (printed “N'000”)
    • The cash-flow reconciliation prints 2023 finance income (308,121) against 681,245 in profit or loss (p34, p36). Reconciliation lines are not transcribed; kept as printed.
    • Basic and diluted earnings per share printed in kobo (467; 2023: 309, p34) is stored in naira (÷100) with the printed figure and unit kept.
    Technical details
    File
    87 pages, with a text layer
    SHA-256
    f1574a4ba316c12ea4e184435cf5751078c22929b5be977bd83e360364f0471b
    Entity as printed
    Chemical and Allied Products Plc ("the Company")
    Exchange copy
    retrieved 2026-10-08T18:06:06Z

Data notes

No figure-level notes beyond those in the tables.

Review status: every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (9 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.

Download

Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.

· Company methodology and coverage